183 related articles for article (PubMed ID: 23418396)
61. Role of glucocorticoids in the regulation of pituitary somatostatin receptor subtype (sst1-sst5) mRNA levels: evidence for direct and somatostatin-mediated effects.
Park S; Kamegai J; Kineman RD
Neuroendocrinology; 2003 Sep; 78(3):163-75. PubMed ID: 14512709
[TBL] [Abstract][Full Text] [Related]
62. Differential temporal and spatial regulation of somatostatin receptor phosphorylation and dephosphorylation.
Ghosh M; Schonbrunn A
J Biol Chem; 2011 Apr; 286(15):13561-73. PubMed ID: 21343287
[TBL] [Abstract][Full Text] [Related]
63. The tyrosine phosphatase SHP-1 associates with the sst2 somatostatin receptor and is an essential component of sst2-mediated inhibitory growth signaling.
Lopez F; Estève JP; Buscail L; Delesque N; Saint-Laurent N; Théveniau M; Nahmias C; Vaysse N; Susini C
J Biol Chem; 1997 Sep; 272(39):24448-54. PubMed ID: 9305905
[TBL] [Abstract][Full Text] [Related]
64. Fish somatostatin sst3 receptor: comparison of radioligand and GTPgammaS binding, adenylate cyclase and phospholipase C activities reveals different agonist-dependent pharmacological signatures.
Siehler S; Nunn C; Zupanc GK; Hoyer D
Auton Autacoid Pharmacol; 2005 Jan; 25(1):1-16. PubMed ID: 15659149
[TBL] [Abstract][Full Text] [Related]
65. Synthesis and evaluation of a ligand targeting the somatostatin-2 receptor for drug delivery to neuroendocrine cancers.
Li G; Low PS
Bioorg Med Chem Lett; 2015 Apr; 25(8):1792-1798. PubMed ID: 25791453
[TBL] [Abstract][Full Text] [Related]
66. Differential beta-arrestin trafficking and endosomal sorting of somatostatin receptor subtypes.
Tulipano G; Stumm R; Pfeiffer M; Kreienkamp HJ; Höllt V; Schulz S
J Biol Chem; 2004 May; 279(20):21374-82. PubMed ID: 15001578
[TBL] [Abstract][Full Text] [Related]
67. The third intracellular loop of the human somatostatin receptor 5 is crucial for arrestin binding and receptor internalization after somatostatin stimulation.
Peverelli E; Mantovani G; Calebiro D; Doni A; Bondioni S; Lania A; Beck-Peccoz P; Spada A
Mol Endocrinol; 2008 Mar; 22(3):676-88. PubMed ID: 18096696
[TBL] [Abstract][Full Text] [Related]
68. The effect of selective sst1, sst2, sst5 somatostatin receptors agonists, a somatostatin/dopamine (SST/DA) chimera and bromocriptine on the "clinically non-functioning" pituitary adenomas in vitro.
Gruszka A; Kunert-Radek J; Radek A; Pisarek H; Taylor J; Dong JZ; Culler MD; Pawlikowski M
Life Sci; 2006 Jan; 78(7):689-93. PubMed ID: 16115652
[TBL] [Abstract][Full Text] [Related]
69. Pasireotide, a multi-somatostatin receptor ligand with potential efficacy for treatment of pituitary and neuroendocrine tumors.
Feelders RA; de Herder WW; Neggers SJ; van der Lely AJ; Hofland LJ
Drugs Today (Barc); 2013 Feb; 49(2):89-103. PubMed ID: 23462624
[TBL] [Abstract][Full Text] [Related]
70. A Critical Evaluation of sst3 and sst5 Immunohistochemistry in Human Pituitary Adenomas.
Körner M; Waser B; Christ E; Beck J; Reubi JC
Neuroendocrinology; 2018; 106(2):116-127. PubMed ID: 28384628
[TBL] [Abstract][Full Text] [Related]
71. Localization and pharmacological characterization of somatostatin sst2 sites in the rat cerebellum.
Piwko C; Thoss VS; Hoyer D
Naunyn Schmiedebergs Arch Pharmacol; 1995 Dec; 352(6):607-13. PubMed ID: 9053731
[TBL] [Abstract][Full Text] [Related]
72. Molecular mechanisms of somatostatin receptor trafficking.
Csaba Z; Peineau S; Dournaud P
J Mol Endocrinol; 2012 Feb; 48(1):R1-12. PubMed ID: 22159161
[TBL] [Abstract][Full Text] [Related]
73. Identification of the somatostatin receptor subtypes (sst) mediating the divergent, stimulatory/inhibitory actions of somatostatin on growth hormone secretion.
Luque RM; Durán-Prado M; García-Navarro S; Gracia-Navarro F; Kineman RD; Malagón MM; Castaño JP
Endocrinology; 2006 Jun; 147(6):2902-8. PubMed ID: 16543371
[TBL] [Abstract][Full Text] [Related]
74. Development of selective antibodies against the human somatostatin receptor subtypes sst1-sst5.
Helboe L; Møller M; Nørregaard L; Schiødt M; Stidsen CE
Brain Res Mol Brain Res; 1997 Oct; 49(1-2):82-8. PubMed ID: 9387866
[TBL] [Abstract][Full Text] [Related]
75. Somatostatin receptors.
Benali N; Ferjoux G; Puente E; Buscail L; Susini C
Digestion; 2000; 62 Suppl 1():27-32. PubMed ID: 10940684
[TBL] [Abstract][Full Text] [Related]
76. Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use.
Reubi JC; Schär JC; Waser B; Wenger S; Heppeler A; Schmitt JS; Mäcke HR
Eur J Nucl Med; 2000 Mar; 27(3):273-82. PubMed ID: 10774879
[TBL] [Abstract][Full Text] [Related]
77. Cell specific interaction of pasireotide: review of preclinical studies in somatotroph and corticotroph pituitary cells.
Gatto F; Arvigo M; Amarù J; Campana C; Cocchiara F; Graziani G; Bruzzone E; Giusti M; Boschetti M; Ferone D
Pituitary; 2019 Feb; 22(1):89-99. PubMed ID: 30483918
[TBL] [Abstract][Full Text] [Related]
78. Activation of adenylate cyclase by human recombinant sst5 receptors expressed in CHO-K1 cells and involvement of Galphas proteins.
Carruthers AM; Warner AJ; Michel AD; Feniuk W; Humphrey PP
Br J Pharmacol; 1999 Mar; 126(5):1221-9. PubMed ID: 10205012
[TBL] [Abstract][Full Text] [Related]
79. [New medical treatments in pituitary adenomas].
Drutel A; Caron P; Archambeaud F
Ann Endocrinol (Paris); 2008 Sep; 69 Suppl 1():S16-28. PubMed ID: 18954854
[TBL] [Abstract][Full Text] [Related]
80. Receptor-specific somatostatin analogs: correlations with biological activity.
Coy DH; Taylor JE
Metabolism; 1996 Aug; 45(8 Suppl 1):21-3. PubMed ID: 8769373
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
